Jesus B. Mantas

This profile gathers the share dealings of Jesus B. Mantas in Biogen Inc., where the filings describe the role as board member. Between 19 June 2019 and 9 June 2026, the trades on record add up to 9 filings.

No open-market sale appears; the market trades are 1 purchase worth €199k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 8 share grants.

The latest filing, published on 11 June 2026, reports a share grant in Biogen Inc. The most recent open-market purchase was published on 10 February 2021, 2,081 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.